HFEA/LinkedIn
Jun 18, 2026, 13:25
Zoe’s Experience Living With The Antiphospholipid Syndrome – HFEA
Human Fertilisation and Embryology Authority (HFEA) shared a post on LinkedIn:
”Antiphospholipid syndrome (APS) is a rare autoimmune disorder affecting around 1 in 2000 people in the UK. It increases the risk of blood clots in various parts of the body. In our latest blog, Zoe, a member of our Patient Engagement Forum, shares her experience living with the condition and the impact that it has had on her fertility journey.
Read Zoe’s blog.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 22, 2026, 12:03Khalil Faaed: A Beautiful Embryo Does Not Guarantee a Competent Oocyte
-
Jun 22, 2026, 08:00Saarthak Bakshi: Male Factor Infertility Highlighted at National IVF Summit 2026
-
Jun 22, 2026, 07:47City Fertility Joins Pink Elephants in Celebrating a Decade of Impact – City Fertility
-
Jun 22, 2026, 07:39Angela Koech: PRECISE Network Findings Point to Targeted Stillbirth Prevention
-
Jun 22, 2026, 07:27Cryopreservation Does Not Always Fail Without Warning – MEFS
-
Jun 21, 2026, 15:55Maha Alasiri: Early Diagnosis of Interstitial Ectopic Pregnancy
-
Jun 21, 2026, 15:51Fabian Laumer: AI-Assisted Detection of Deep Endometriosis
-
Jun 21, 2026, 15:48Alejandro González: What the Latest ESHRE 2025 Guidelines Tell Us on IVF Pretreatments
-
Jun 21, 2026, 15:43Expert Perspectives on Recurrent Pregnancy Loss and Family Support – ACOOG